Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
NeuPath Health Inc. is a Canada-based healthcare services company focused on the mental health and neurological care sectors. The company operates an integrated network of outpatient clinics that provide diagnosis, treatment, and ongoing management for patients with mental health and complex neurological conditions. Its services are delivered primarily through physician-led, multidisciplinary clinical settings, positioning the company within the specialty healthcare and mental health services industries.
NeuPath Health’s primary revenue is generated through clinical services reimbursed by provincial healthcare systems, private insurers, and self-pay patients. The company targets underserved patient populations requiring specialized mental health and neurological care, with an emphasis on reducing wait times and improving continuity of care. NeuPath Health was founded in 2018 and has grown through a combination of organic clinic development and acquisitions, transitioning from a neurology-focused platform to a broader mental health services provider as demand for outpatient psychiatric care increased in Canada.
Business Operations
NeuPath Health operates through two core business segments: Mental Health Clinics and Neurology Clinics, which together form an integrated outpatient care platform. The Mental Health Clinics segment provides psychiatric assessments, psychotherapy, and ongoing treatment for conditions such as depression, anxiety, ADHD, PTSD, and mood disorders. The Neurology Clinics segment delivers diagnostic and treatment services for neurological conditions, including epilepsy, concussion, chronic pain, and sleep disorders.
Operations are primarily domestic, with clinics located across multiple Canadian provinces. The company controls clinic infrastructure, proprietary clinical workflows, and centralized administrative functions, including billing and patient intake systems. NeuPath Health has expanded through acquisitions of established outpatient practices, which are typically retained as wholly owned subsidiaries and integrated into its broader operating platform while maintaining local clinical leadership.
Strategic Position & Investments
NeuPath Health’s strategy centers on scaling a national outpatient mental health platform by acquiring and integrating established clinics, expanding service offerings, and increasing patient throughput. Growth initiatives have included the acquisition of operating mental health clinics and investments in clinical staffing, digital patient intake systems, and standardized care pathways to improve operational efficiency.
The company has made targeted acquisitions of outpatient mental health clinic operators and neurology practices, which are incorporated into its platform under existing clinic brands. NeuPath Health has also invested in expanding psychiatric and psychotherapy capacity to address persistent supply-demand imbalances in Canada’s publicly funded mental health system. Its strategic focus remains on regulated healthcare services rather than experimental or unproven technologies.
Geographic Footprint
NeuPath Health’s operations are concentrated in Canada, with a clinic presence across Ontario, British Columbia, Alberta, and other select provinces. The company is headquartered in Toronto, Ontario, which also serves as its primary administrative and strategic hub.
While NeuPath Health does not currently operate clinics outside Canada, its geographic footprint spans multiple urban and suburban markets with high demand for outpatient mental health services. The company’s expansion strategy emphasizes regional density within provinces rather than international operations, allowing for centralized administration and consistent clinical standards.
Leadership & Governance
NeuPath Health is led by executives with backgrounds in healthcare operations, finance, and clinical practice. The leadership team emphasizes disciplined acquisition, clinical quality, and scalable healthcare delivery within Canada’s regulated system. Governance is overseen by a board of directors with experience in public markets, healthcare services, and professional practice management.
Key executives include:
- Corey Mitchell – Chief Executive Officer
- Michael J. Lavigne – Chief Financial Officer
- Dr. Bradley Stewart – Chief Medical Officer
- Peter Gill – Executive Chairman
The leadership team’s strategic vision focuses on building a leading national outpatient mental health platform while maintaining physician engagement and adherence to provincial healthcare regulations.